Načítá se...
Aldehyde dehydrogenase 1A1—a new mediator of resistance to temozolomide in glioblastoma
Implementation of chemotherapy with the drug temozolomide increased the overall survival of patients with glioblastoma multiforme (GBM; WHO grade IV), in particular when the O(6)-methylguanine DNA methyltransferase (MGMT) promoter is epigenetically silenced. Nevertheless, the prognosis remains poor,...
Uloženo v:
Hlavní autoři: | , , , , , , , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Oxford University Press
2012
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3499020/ https://ncbi.nlm.nih.gov/pubmed/23132408 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nos270 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|